Those who took it consistently over time benefited years later
(NEWSER) - Aspirin has long been touted as a means of protecting yourself from heart disease, and now a new study suggests it could dramatically lessen your cancer risk, too. Researchers looked at eight past aspirin trials, and found that patients who took aspirin, rather than a placebo, were 21% less likely to die of solid tumor cancers 20 years later, the New York Times reports. The dose taken doesn't seem to matter (and can be as small as 75 to 100 milligrams), but the longer the aspirin was taken, the lower the risk. More»